132 related articles for article (PubMed ID: 20413561)
1. Effect of glutathione on the cadmium chelation of EDTA in a patient with cadmium intoxication.
Gil HW; Kang EJ; Lee KH; Yang JO; Lee EY; Hong SY
Hum Exp Toxicol; 2011 Jan; 30(1):79-83. PubMed ID: 20413561
[TBL] [Abstract][Full Text] [Related]
2. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
Lin JL; Lin-Tan DT; Hsu KH; Yu CC
N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
Lin-Tan DT; Lin JL; Yen TH; Chen KH; Huang YL
Nephrol Dial Transplant; 2007 Oct; 22(10):2924-31. PubMed ID: 17556414
[TBL] [Abstract][Full Text] [Related]
4. Low-level environmental exposure to lead and progressive chronic kidney diseases.
Lin JL; Lin-Tan DT; Li YJ; Chen KH; Huang YL
Am J Med; 2006 Aug; 119(8):707.e1-9. PubMed ID: 16887418
[TBL] [Abstract][Full Text] [Related]
5. [Case of lead nephropathy due to chronic occupational lead exposure].
Ogata A; Sueta S; Tagawa M
Nihon Jinzo Gakkai Shi; 2011; 53(2):207-11. PubMed ID: 21516708
[TBL] [Abstract][Full Text] [Related]
6. Biomonitoring of the adverse effects induced by the chronic exposure to lead and cadmium on kidney function: usefulness of alpha-glutathione S-transferase.
Garçon G; Leleu B; Marez T; Zerimech F; Haguenoer JM; Furon D; Shirali P
Sci Total Environ; 2007 May; 377(2-3):165-72. PubMed ID: 17379277
[TBL] [Abstract][Full Text] [Related]
7. Serum beta2-microglobulin in cadmium exposed workers.
Piscator M
Pathol Biol (Paris); 1978 Sep; 26(6):321-3. PubMed ID: 83573
[TBL] [Abstract][Full Text] [Related]
8. Integrated index of occupational exposure to cadmium as a predictor of kidney dysfunction.
Jakubowski M; Razniewska G; Halatek T; Trzcinka-Ochocka M
IARC Sci Publ; 1992; (118):319-24. PubMed ID: 1303958
[TBL] [Abstract][Full Text] [Related]
9. ["Terzo fuoco", lead poisoning and chronic renal failure].
Bonucchi D; Mondaini G; Ravera F; Minisci E; Albertazzi V; Arletti S; Mori G; Ballestri M; Piattoni J; Cappelli G
G Ital Nefrol; 2007; 24 Suppl 38():76-9. PubMed ID: 17922453
[TBL] [Abstract][Full Text] [Related]
10. Integrated indexes of occupational exposure as predictors of kidney dysfunction.
Jakubowski M; Trzcinka-Ochocka M; Hałatek T; Raźniewska G; Szymczak W
Int J Occup Med Environ Health; 2002; 15(4):393-9. PubMed ID: 12608627
[TBL] [Abstract][Full Text] [Related]
11. A comparison of diethyldithiocarbamate and EDTA as antidotes for acute cadmium intoxication.
Jones SG; Basinger MA; Jones MM; Gibbs SJ
Res Commun Chem Pathol Pharmacol; 1982 Nov; 38(2):271-8. PubMed ID: 6298916
[TBL] [Abstract][Full Text] [Related]
12. Lack of reversal effect of EDTA treatment on cadmium induced renal dysfunction: a fourteen-year follow-up.
Wu X; Su S; Zhai R; Chen K; Jin T; Huang B; Zhou Y; Ge X; Wei G; Liao R
Biometals; 2004 Aug; 17(4):435-41. PubMed ID: 15259364
[TBL] [Abstract][Full Text] [Related]
13. [Cadmium toxicity: summary of personal studies].
Lauwerys R; Buchet JP; Roels H; Bernard A
Toxicol Eur Res; 1982 Jan; 4(1):7-17. PubMed ID: 7051422
[TBL] [Abstract][Full Text] [Related]
14. EDTA redistribution of lead and cadmium into the soft tissues in a human with a high lead burden - should DMSA always be used to follow EDTA in such cases?
Crinnion WJ
Altern Med Rev; 2011 Jun; 16(2):109-12. PubMed ID: 21649453
[TBL] [Abstract][Full Text] [Related]
15. Blood and urine cadmium and bioelements profile in nickel-cadmium battery workers in Serbia.
Bulat ZP; Dukic-Cosic D; Dokic M; Bulat P; Matovic V
Toxicol Ind Health; 2009 Mar; 25(2):129-35. PubMed ID: 19458135
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of cadmium among Torres Strait Islanders (Australia) at risk of elevated dietary exposure through traditional foods.
Haswell-Elkins M; Imray P; Satarug S; Moore MR; O'dea K
J Expo Sci Environ Epidemiol; 2007 Jul; 17(4):372-7. PubMed ID: 16912696
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal complexation haemodialysis for the treatment of cadmium poisoning. II. In vivo mobilization and removal.
Sheabar FZ; Yannai S; Taitelman U
Pharmacol Toxicol; 1989 Jul; 65(1):13-6. PubMed ID: 2506542
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity.
Roels HA; Hoet P; Lison D
Ren Fail; 1999; 21(3-4):251-62. PubMed ID: 10416202
[TBL] [Abstract][Full Text] [Related]
19. Renal effects of cadmium exposure in cadmium nonpolluted areas in Japan.
Suwazono Y; Kobayashi E; Okubo Y; Nogawa K; Kido T; Nakagawa H
Environ Res; 2000 Sep; 84(1):44-55. PubMed ID: 10991781
[TBL] [Abstract][Full Text] [Related]
20. Urinary proteoglycans after cadmium exposure.
Savolainen H
Res Commun Chem Pathol Pharmacol; 1993 Nov; 82(2):241-4. PubMed ID: 8303093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
